TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
TNGX

Tango Therapeutics Inc

Healthcare · Biotechnology · —

21.80$ -7.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement TNGX
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
130.9% 21.2% 5.3% 16.2% 315.4% 5.9% 3.7%
-30.9% 78.8% 100.0% 100.0% 100.0% 100.0% 96.3%
130.9% 653.0% 209.6% 426.0% 315.4% 342.1% 211.9%
30.6% 128.9% 47.5% 120.8% 97.2% 104.0% 66.5%
30.6% 760.6% 257.1% 546.8% 412.6% 446.1% 274.7%
-61.5% -681.8% -157.1% -446.8% -312.6% -346.1% -178.4%
0.0% 0.0% 3.1% 11.9%
-57.2% -678.8% -156.4% -434.9% -278.2% -309.2% -162.8%
-1.4% 0.8% 0.2% 0.4% 0.5% 0.0%
-57.2% -678.8% -157.2% -435.1% -278.5% -309.7% -162.9%
-58.9% -657.6% -154.7% -440.3% -271.6% -303.3% -159.2%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?